JPWO2023112965A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023112965A5
JPWO2023112965A5 JP2023567818A JP2023567818A JPWO2023112965A5 JP WO2023112965 A5 JPWO2023112965 A5 JP WO2023112965A5 JP 2023567818 A JP2023567818 A JP 2023567818A JP 2023567818 A JP2023567818 A JP 2023567818A JP WO2023112965 A5 JPWO2023112965 A5 JP WO2023112965A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
vhh antibody
dimer
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023567818A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023112965A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/046069 external-priority patent/WO2023112965A1/ja
Publication of JPWO2023112965A1 publication Critical patent/JPWO2023112965A1/ja
Publication of JPWO2023112965A5 publication Critical patent/JPWO2023112965A5/ja
Pending legal-status Critical Current

Links

JP2023567818A 2021-12-15 2022-12-14 Pending JPWO2023112965A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021203699 2021-12-15
PCT/JP2022/046069 WO2023112965A1 (ja) 2021-12-15 2022-12-14 Ｖｈｈ抗体

Publications (2)

Publication Number Publication Date
JPWO2023112965A1 JPWO2023112965A1 (https=) 2023-06-22
JPWO2023112965A5 true JPWO2023112965A5 (https=) 2025-08-27

Family

ID=86774409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023567818A Pending JPWO2023112965A1 (https=) 2021-12-15 2022-12-14

Country Status (4)

Country Link
US (1) US20250136669A1 (https=)
EP (1) EP4450518A4 (https=)
JP (1) JPWO2023112965A1 (https=)
WO (1) WO2023112965A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025033553A1 (ja) * 2023-08-10 2025-02-13 国立大学法人 東京大学 新規なｈｖｅｍ結合タンパク質およびそれを含む医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5314286B2 (ja) 2006-02-10 2013-10-16 学校法人東海大学 緑膿菌の薬剤排出ポンプの機能を阻害する方法及び薬剤
GB201115214D0 (en) * 2011-09-02 2011-10-19 Health Prot Agency Influenza virus antibody compositions
CA2855894A1 (en) * 2011-12-20 2013-06-27 Merck Sharp & Dohme Corp. Pseudomonas aeruginosa oprm epitopes for use in diagnostics and therapeutics
EP2820043B1 (en) * 2012-03-02 2020-01-15 Ablynx N.V. Biparatopic pseudomonas aeruginosa pcrv binding single variable domain antibodies
CN104870472A (zh) * 2012-10-24 2015-08-26 加拿大国家研究委员会 抗空肠弯曲杆菌抗体及其用途
EP3573997A4 (en) * 2017-01-24 2020-12-09 Abexxa Biologics, Inc. METHODS AND COMPOSITIONS INTENDED TO TARGE A COMPLEX INCLUDING A NON-CLASSIC HLA-I AND A NEO-ANTIGEN IN THE TREATMENT OF CANCER
WO2020080941A1 (en) * 2018-10-16 2020-04-23 Umc Utrecht Holding B.V. Anti- low-density lipoprotein receptor-related protein 5/6 antibodies
CA3143735A1 (en) * 2019-07-03 2021-01-07 Lumen Bioscience, Inc. Arthrospira platensis non-parenteral therapeutic delivery platform

Similar Documents

Publication Publication Date Title
Nuti et al. Antimicrobial peptides: a promising therapeutic strategy in tackling antimicrobial resistance
DK2970455T3 (en) Anti-C5 antibodies with improved pharmacokinetics
JP2017529097A5 (https=)
BR112019002848A2 (pt) anticorpo anti-lag-3
EP2532365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
MX2019007719A (es) Anticuerpo anti-receptor de transferrina humana novedoso capaz de penetrar la barrera hematoencefalica.
JP2017532313A5 (https=)
JPWO2023112965A5 (https=)
RU2017115670A (ru) Лечение инфекции рсв
HRP20160082T1 (hr) Sastavi i postupci za dijagnosticiranje i lijeäśenje raka
CN116997353A (zh) 对SARS-CoV-2糖蛋白S具有中和活性的治疗抗体
JP2014221758A5 (https=)
JP2013520405A5 (https=)
JP2020507561A5 (https=)
WO2016094834A2 (en) A method for treating a complement mediated disorder caused by an infectious agent in a patient
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
CY1120810T1 (el) Φαρμακευτικη συνθεση για την παρασκευη διαλυματων εγχυσης αντιμικροβιακων παρασκευασματων, η μεθοδος παραγωγης αυτης
JP2015517492A5 (https=)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
NZ602964A (en) Remedies for pemphigus containing anti fas ligand antibodies
JP2025165988A (ja) プラスミノーゲンとの結合のための抗体
EA202191880A1 (ru) Композиции, содержащие аминокислоты, для применения и лечения повреждений центральной нервной системы
EA202090143A1 (ru) Фармацевтически приемлемые соли полипептидов и их применение
EA201991490A1 (ru) Ароматические амиды карбоновых кислот в качестве антагонистов рецепторов брадикинина в1
CA3010564A1 (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition